Treasury Secretary Steven MnuchinSteven MnuchinMenendez, Rubio ask Yellen to probe meatpacker JBS The Hill's Morning Report - Presented by Goldman Sachs - Biden rallies Senate Dems behind mammoth spending plan Mnuchin dodges CNBC questions on whether Trump lying over election MORE said Thursday that President TrumpDonald TrumpUN meeting with US, France canceled over scheduling issue Trump sues NYT, Mary Trump over story on tax history McConnell, Shelby offer government funding bill without debt ceiling MORE is open to invoking the Defense Production Act (DPA) again for the production of a future coronavirus vaccine.
The DPA is “a very important tool, it should be used carefully,” Mnuchin said Thursday in an interview with The Hill's Editor-in-Chief Bob CusackRobert (Bob) CusackAl Eisele, founding editor of The Hill, dies at 85 The Hill's 12:30 Report - Presented by Facebook - Tensions rise as U.S. waits for Derek Chauvin verdict Key Democrat says traveler fees should fund infrastructure projects MORE for the Advancing America's Economy virtual event.
“I know the president is very much willing to use it if we need to use it. I got an update on vaccines yesterday and the investments that BARDA [the Biomedical Advanced Research and Development Authority] is making, which I think is really terrific and in many cases they have commitments to take over large amounts of the vaccines,” he said.
“The DPA is a very important tool to protect the American workers, and if the president needs to use it he will,” Mnuchin added.
The DPA, established in 1950 during the Korean War, allows the president to require businesses to prioritize production of essential materials for national defense.
Trump had already invoked it during the coronavirus pandemic for the production of ventilators and personal protective gear, as well as when he signed an executive order requiring meat production plants to remain open.
The Hill’s event was sponsored by Wells Fargo and Siemen’s.